Bio Protocol

Bio Protocol

Decentralized biotech funding via IP NFTs

Overview

PsyDAO is a decentralized biotech protocol that creates a marketplace for research and an IP NFT framework. It funds biotech projects—particularly in cryopreservation—by offering up to $100,000 per project and connecting academics, biotech companies, investors, and patients in a fully governance-driven community. Powered by Molecule, PsyDAO reviews applications for new cohorts and supports DAO founders with a network of experienced contributors, enabling direct ownership and control of research IP through IP NFTs. Unlike traditional funding models, PsyDAO blends DeSci principles with an open-source ethos, allowing patients, researchers, and investors to govern and benefit from research outcomes. Its goal is to accelerate biotech research by providing rapid, community-governed funding and a novel IP framework that unlocks data access and legal rights for research.

About Bio Protocol

Simplify's Rating
Why Bio Protocol is rated
C-
Rated C on Competitive Edge
Rated C on Growth Potential
Rated D+ on Differentiation

Industries

Enterprise Software

Crypto & Web3

Biotechnology

Company Size

11-50

Company Stage

Seed

Total Funding

$71.3M

Headquarters

Nantes, France

Founded

2022

People at Bio Protocol

People at Bio Protocol who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • AI slashed drug discovery to 24 hours at $1,500, enabling decentralised science funding models.
  • Bio Protocol secured $64.4M public funding and Binance Labs investment to expand BioDAO ecosystem.
  • Tokenized scientific IP target market reaches hundreds of billions, driving BIO token value gains.

What critics are saying

  • Crypto narrative volatility kills patient capital; 40-60% probability token holders exit before Phase I unblinding.
  • AI drug discovery overhype may trigger regulatory rejection without wet-lab validation; 30-50% probability in 12-18 months.
  • VitaDAO-Gero deal with Roche displaces Bio Protocol niche; 25-40% probability of 9-figure pharma valuation competition.

What makes Bio Protocol unique

  • Bio Protocol is a token-governed DeSci platform routing capital to research DAOs for AI-driven drug discovery.
  • It pioneers IP NFTs granting full legal research IP rights and data access control in biomedical science.
  • The platform integrates community funding with agentic science via BIOS, an AI scientist coordinating specialized agents.

Help us improve and share your feedback! Did you find this helpful?

Funding

Total Funding

$71.3M

Above

Industry Average

Funded Over

2 Rounds

Seed funding is usually the first official round after pre-seed, when a startup has a prototype or concept. It’s typically used to develop the product, test the market, and start building the team. Investors here are often angel investors or early-stage venture capitalists.
Seed Funding Comparison
Above Average

Industry standards

$3.3M
$2M
Netflix
$2.3M
Instacart
$3M
Robinhood
$6.9M
Bio Protocol

Benefits

Remote Work Options

Flexible Work Hours

Company Equity

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

0%

2 year growth

0%
CoinFactiva
Jan 7th, 2025
BIO Protocol Secures $64.4M Funding

BIO Protocol secured $64.4M in a public sale to advance its decentralized science platform. Other notable funding rounds include Haedal's undisclosed seed funding for liquid staking on Sui blockchain, Hyperfluid's pre-seed round for its hybrid DEX on Aptos, and Fold's $20M round for expanding Bitcoin rewards. Additional rounds featured Accountable's $2.3M seed funding for a privacy-focused data platform and Silencio's $1.3M public sale to combat noise pollution.

Recently Posted Jobs

Sign up to get curated job recommendations

There are no jobs for Bio Protocol right now.

Find jobs on Simplify and start your career today

We update Bio Protocol's jobs every few hours, so check again soon! Browse all jobs →